Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTranslational Development Acquisition Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | N/A | $0.08 | N/A | N/A | $0 |
| 08/14/2025 | Q2 2025 | N/A | $0.07 | N/A | N/A | $191.76 K |
| 05/15/2025 | Q1 2025 | N/A | $0.37 | N/A | N/A | $223.85 K |
| 04/21/2025 | Q4 2024 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.02 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.00 | N/A | N/A | $0 |
| 04/09/2025 | Q4 2023 | N/A | -$0.12 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 05/31/2022 | Q2 2022 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Translational Development Acquisition Corp. Earnings: FAQ's
Translational Development Acquisition Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, September 15th, 2025 based offlast year's report dates.
The conference call for Translational Development Acquisition Corp.'s latest earnings report can be listened to online.
The conference call transcript for Translational Development Acquisition Corp.'s latest earnings report can be read online.
Translational Development Acquisition Corp. (:TDAC) has a recorded annual revenue of $1,065.79 B.
Translational Development Acquisition Corp. (:TDAC) has a recorded net income of $-71,012.Translational Development Acquisition Corp. has generated $-0.0162 earnings per share over the last four quarters.
Translational Development Acquisition Corp. (:TDAC) has a price-to-earnings ratio of 37.85 and price/earnings-to-growth ratio is 1.81.